G 
23.72
-0.08%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥12.91bn
FY2021FY2025
Net income
CN¥3.11bn
FY2021FY2025
Free cash flow
CN¥2.22bn
FY2021FY2025
Shareholders' equity
CN¥5.83bn
FY2021FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | CN¥12.91bn | CN¥7.53bn | CN¥6.58bn | CN¥4.76bn | CN¥4.38bn |
| Gross profit | CN¥4.26bn | CN¥2.30bn | CN¥2.06bn | CN¥1.34bn | CN¥1.31bn |
| Research and development | CN¥217.6m | CN¥199.4m | CN¥170.3m | CN¥101.4m | CN¥65.0m |
| Operating income | CN¥3.28bn | CN¥1.57bn | CN¥1.50bn | CN¥895.9m | CN¥980.6m |
| Net income | CN¥3.11bn | CN¥1.27bn | CN¥925.3m | CN¥314.2m | CN¥20.1m |
| Diluted earnings per share | 1.31 | 0.67 | 0.40 | 0.13 | 0.01 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Total assets | CN¥16.66bn | CN¥5.89bn | CN¥4.42bn | CN¥2.60bn | CN¥2.04bn |
| Cash and short-term investments | CN¥12.15bn | CN¥2.73bn | CN¥2.25bn | CN¥1.02bn | CN¥393.5m |
| Total liabilities | CN¥10.81bn | CN¥4.08bn | CN¥3.89bn | CN¥3.30bn | CN¥3.25bn |
| Debt | CN¥6.52bn | CN¥2.88bn | CN¥166.4m | CN¥2.51bn | CN¥127.5m |
| Shareholders' equity | CN¥5.83bn | CN¥1.77bn | CN¥499.7m | −CN¥713.4m | −CN¥1.22bn |
| Shares outstanding | 2,379m | 1,887m | 2,333m | 2,378m | 2,378m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Cash from operations | CN¥2.45bn | CN¥1.13bn | CN¥1.35bn | CN¥866.6m | CN¥267.5m |
| Capital spending | −CN¥231.0m | −CN¥385.8m | −CN¥341.8m | −CN¥170.6m | −CN¥164.6m |
| Free cash flow | CN¥2.22bn | CN¥746.0m | CN¥1.01bn | CN¥696.0m | CN¥102.9m |
| Dividends paid | −CN¥1.45bn | — | — | — | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥3.74bn | CN¥3.74bn | CN¥3.63bn | CN¥3.63bn | CN¥2.83bn | CN¥2.83bn | CN¥2.01bn | CN¥5.52bn |
| Gross profit | CN¥1.25bn | CN¥1.25bn | CN¥1.24bn | CN¥1.24bn | CN¥893.0m | CN¥893.0m | CN¥619.7m | CN¥1.68bn |
| Operating income | CN¥1.01bn | CN¥1.01bn | CN¥966.8m | CN¥966.8m | CN¥671.2m | CN¥671.2m | CN¥419.8m | CN¥1.15bn |
| Net income | CN¥785.4m | CN¥785.4m | CN¥741.8m | CN¥741.8m | CN¥812.7m | CN¥812.7m | CN¥318.8m | CN¥948.3m |
| Diluted earnings per share | 0.33 | 0.33 | 0.31 | 0.31 | 0.34 | 0.34 | 0.17 | 0.50 |
| Cash from operations | — | — | CN¥534.0m | CN¥534.0m | CN¥670.0m | CN¥670.0m | CN¥164.0m | CN¥967.0m |
| Capital spending | — | — | −CN¥68.0m | −CN¥68.0m | −CN¥55.0m | −CN¥55.0m | −CN¥99.0m | −CN¥285.0m |
| Free cash flow | — | — | CN¥466.0m | CN¥466.0m | CN¥615.0m | CN¥615.0m | CN¥65.0m | CN¥682.0m |
| Total assets | CN¥15.48bn | CN¥15.48bn | CN¥16.65bn | CN¥16.65bn | CN¥10.67bn | CN¥10.67bn | CN¥5.89bn | CN¥5.44bn |
| Cash and short-term investments | CN¥4.25bn | CN¥4.25bn | CN¥5.67bn | CN¥5.68bn | CN¥5.13bn | CN¥5.13bn | CN¥2.73bn | CN¥2.84bn |
| Debt | CN¥5.68bn | CN¥5.68bn | CN¥6.52bn | CN¥6.35bn | CN¥1.74bn | CN¥1.53bn | CN¥2.88bn | CN¥156.1m |
| Shareholders' equity | CN¥6.30bn | CN¥6.30bn | CN¥5.82bn | CN¥5.82bn | CN¥6.35bn | CN¥6.35bn | CN¥1.77bn | CN¥1.44bn |
Financial ratios
Data as of 15 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Gross margin | 33.9% | 30.6% | 31.3% | 28.1% | 30.0% |
| Operating margin | 23.7% | 20.9% | 22.7% | 18.8% | 22.4% |
| Net margin | 24.1% | 16.8% | 14.1% | 6.6% | 0.5% |
| Return on equity | 52.0% | 71.6% | 185.2% | -44.0% | -1.7% |
| Return on assets | 18.2% | 21.5% | 21.0% | 12.1% | 1.0% |
| Free cash flow yield | 5.0% | 4.2% | 3.8% | — | — |
| Revenue growth | 43.1% | 14.5% | 38.1% | 26.8% | — |
| Earnings growth | 104.8% | 36.9% | 194.5% | 1720.4% | — |
| Current ratio | 1.39x | 1.09x | 0.92x | 0.59x | 0.44x |
| Debt to equity | 1.12x | 1.62x | 0.29x | -3.45x | -0.08x |
| Equity ratio | 35.0% | 30.1% | 11.3% | -27.5% | -59.5% |
| Interest coverage | 41.33x | 549.22x | 333.37x | 192.73x | 193.06x |
| R&D as a share of sales | 1.7% | 2.6% | 2.6% | 2.1% | 1.5% |
| Buybacks as a share of market value | -26.1% | 19.1% | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 39.7% | — | — |
| Operating income | 54.1% | — | — |
| Net income | 114.7% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 32.1% | 31.3% | — | — |
Valuation history
At each fiscal year end
| FY2025 | |
|---|---|
| Price to earnings | 17.0 |
| Price to sales | 4.1 |
Dividends and splits
Per share, in the currency the company pays
Paid for 1 years. Last went ex-dividend on 8 Dec 2025.
| FY2025 | |
|---|---|
| Paid in the year | 0.93 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.